To include your compound in the COVID-19 Resource Center, submit it here.

TNT009: Interim Phase Ib data

Interim data from 5 patients with cold agglutinin disease (CAD) in Part C of a 3-part, double-blind, Austrian Phase Ib trial showed that a single dose of 10 mg/kg IV

Read the full 307 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE